Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Codrin Lungu

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Parkinson'S Disease|June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopRoger A Barker, Anders Björklund, Don M Gash, et al.
Trials|October 6, 2022
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trialCharity G Patterson, Elizabeth Joslin, Alexandra B Gil, et al.
The International Journal of Neuroscience|December 20, 2014
Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the PipelineAysegul Gunduz, Hokuto Morita, P Justin Rossi, et al.
Frontiers in Neuroscience|April 20, 2016
Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesP Justin Rossi, Aysegul Gunduz, Jack Judy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 14, 2020
Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohortMelanie T Gentry, Maria I Lapid, Jeremy Syrjanen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesEliana Marisa Ramos, Deepika Reddy Dokuru, Victoria Van Berlo, et al.
Neurobiology of Aging|October 5, 2019
Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriersQin Chen, Bradley F Boeve, Christopher G Schwarz, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS ConsortiumToji Miyagawa, Danielle Brushaber, Jeremy Syrjanen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 25, 2019
Nonlinear Z-score modeling for improved detection of cognitive abnormalityJohn Kornak, Julie Fields, Walter Kremers, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Parkinson'S Disease|June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopRoger A Barker, Anders Björklund, Don M Gash, et al.
Trials|October 6, 2022
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trialCharity G Patterson, Elizabeth Joslin, Alexandra B Gil, et al.
The International Journal of Neuroscience|December 20, 2014
Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the PipelineAysegul Gunduz, Hokuto Morita, P Justin Rossi, et al.
Frontiers in Neuroscience|April 20, 2016
Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesP Justin Rossi, Aysegul Gunduz, Jack Judy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 14, 2020
Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohortMelanie T Gentry, Maria I Lapid, Jeremy Syrjanen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesEliana Marisa Ramos, Deepika Reddy Dokuru, Victoria Van Berlo, et al.
Neurobiology of Aging|October 5, 2019
Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriersQin Chen, Bradley F Boeve, Christopher G Schwarz, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS ConsortiumToji Miyagawa, Danielle Brushaber, Jeremy Syrjanen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 25, 2019
Nonlinear Z-score modeling for improved detection of cognitive abnormalityJohn Kornak, Julie Fields, Walter Kremers, et al.
Pageof 6